Northwest Compounding Pharmacy Recalls Methocarbamol Liquid Due to Sterility Concerns
Northwest Compounding Pharmacy is recalling Methocarbamol liquid 100mg/ml glass vials due to a lack of sterility assurance. The product was distributed in Oregon to medical facilities and patients.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. Per the rubric, FDA Class II recalls involving potential hospitalization or significant injury risks (such as sterility failures in injectable/liquid medications) are rated as Severe.
Plain-English summary
Hiers Enterprises, LLC dba Northwest Compounding Pharmacy is recalling Methocarbamol liquid 100mg/ml, prescription (RX), glass vials (300 ml). The recall was initiated because of a lack of sterility assurance in the product.
The affected product was distributed exclusively in the state of Oregon to three medical facilities, one physician's office, and 80 consumers or patients. The specific lots involved are identified by the codes 10082018@34 (expiration date 1/6/19) and 10312018@27 (expiration date 1/29/19). Because these are compounded products, labels vary for each compound and are specific to each patient; the firm did not provide specific labeling details in the notice.
Consumers and healthcare providers who have this product should stop using it and contact their healthcare provider or the recalling firm for instructions on return or disposal.
The recalled product
- Product
- Methocarbamol liquid 100mg/ml, RX, glass vial
- Category
- Drug — Compounded Prescription
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- 10082018@34 exp 1/6/19
- 10312018@27 exp 1/29/19
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 17 recalled by Hiers Enterprises, LLC dba Northwest Compounding Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 17 products in this recall →Related recalls
Same manufacturer · Hiers Enterprises, LLC dba Northwest Compounding Pharmacy
See all →- SevereNorthwest Compounding Pharmacy Recalls Testosteron Cypionate Liquid Due to Sterility Concerns
FDA (Drugs) · 2019-01-09
- SevereNorthwest Compounding Pharmacy Recalls Lidocaine Gel 1% Due to Sterility Concerns
FDA (Drugs) · 2019-01-09
- SevereNorthwest Compounding Pharmacy Recalls Cyclosporin Liquid Due to Sterility Concerns
FDA (Drugs) · 2019-01-09
- SevereNorthwest Compounding Pharmacy Recalls Cyclosporin Liquid Due to Sterility Concerns
FDA (Drugs) · 2019-01-09
- SevereNorthwest Compounding Pharmacy Recalls Cyclosporin Liquid Due to Sterility Concerns
FDA (Drugs) · 2019-01-09
Same hazard · lack of sterility
See all →- SevereK.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Multiple Brands of Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-09-30
- SevereGentle Eyes Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
Similar recalls
- SevereRecall of Injectable Methylcobalamin Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-11-12
- SevereRecall of Injectable Methycobalamin Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-11-12
- SevereFDA Recalls Injectable Methycobalamin Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-11-12
- SevereFDA Recalls Hydroxocobalamin Injectable Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-11-12
- SevereFDA Recalls Methycobalamin Injectable Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-11-12
- SevereMitomycin Injectable Vials Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2014-11-12